IP Verse

Actavis Elizabeth LLC et al. vs Novartis Pharmaceuticals Corporation

The detailed information for PTAB case with proceeding number IPR2017-01946 filed by Actavis Elizabeth LLC et al. against Novartis Pharmaceuticals Corporation on Aug 15, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-01946
Filing Date: Aug 15, 2017
Petitioner: Actavis Elizabeth LLC et al.
Respondent: Novartis Pharmaceuticals Corporation
Status: Final Written Decision
Respondent Application Number: 14257342
Respondent Tech Center: 1600
Respondent Patent Number: 9187405
Institution Decision Date: Sep 11, 2017
Termination Date: Aug 7, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Final Written Decision IPR2017-00854 (IPR2017-01946 Joined with this proceeding)	Aug 7, 2018	PAPER	BOARD
Order - Conduct of the Proceeding - Discovery under 37 CFR 41.51(b)(1); Ordering Briefing on Discovery under 37 CFR 41.52(b)(2)	Jan 11, 2018	PAPER	BOARD
Notice of Deposition of Dr. Barbara S. Giesser	Sep 26, 2017	PAPER	PATENT OWNER
DECISION - Instituting Inter Partes Review and Granting Motion for Joinder	Sep 11, 2017	PAPER	BOARD
Ex. 3001	Sep 11, 2017	EXHIBIT	BOARD
PO Mandatory Notice	Sep 5, 2017	PAPER	PATENT OWNER
PO Power of Attorney	Sep 5, 2017	PAPER	PATENT OWNER
Notice of Accord Filing Date	Aug 25, 2017	PAPER	BOARD
Petitioners' Supplemental Power of Attorney	Aug 16, 2017	PAPER	PETITIONER
Petitioners' Updated Mandatory Notices	Aug 16, 2017	PAPER	PETITIONER
Petitioners Actavis Elizabeth LLC and Teva Pharmaceuticals USA, Inc.'s Power of Attorney	Aug 15, 2017	PAPER	PETITIONER
U.S. Patent No. 9,187,405	Aug 15, 2017	EXHIBIT	PETITIONER
Declaration of Dr. Barbara S. Giesser	Aug 15, 2017	EXHIBIT	PETITIONER
Curriculum Vitae of Dr. Barbara S. Giesser	Aug 15, 2017	EXHIBIT	PETITIONER
WO 2006/058316	Aug 15, 2017	EXHIBIT	PETITIONER
Thomson, FTY720 in Multiple Sclerosis	Aug 15, 2017	EXHIBIT	PETITIONER
U. S. Patent No. 6,004,565 (Chiba)	Aug 15, 2017	EXHIBIT	PETITIONER
Kappos, L., et al., FTY720 in Relapsing MS	Aug 15, 2017	EXHIBIT	PETITIONER
Budde, et al., First Human Trial of FTY720, a Novel Immunomodulatory, in Stable Renal Transplant Patients	Aug 15, 2017	EXHIBIT	PETITIONER
File History U.S. Patent Application No. 12/303,765	Aug 15, 2017	EXHIBIT	PETITIONER
File History U.S. Patent Application No. 13/149,468	Aug 15, 2017	EXHIBIT	PETITIONER
File History U.S. Patent Application No. 14/257,342	Aug 15, 2017	EXHIBIT	PETITIONER
GB 0612721.1	Aug 15, 2017	EXHIBIT	PETITIONER
U.S. Pat. No. 8,741,963	Aug 15, 2017	EXHIBIT	PETITIONER
File History of U.S. Patent Application No. 11/720,205	Aug 15, 2017	EXHIBIT	PETITIONER
Provisional Patent Application No. 60/631,483	Aug 15, 2017	EXHIBIT	PETITIONER
Virley, Developing Therapeutics for the Treatment of Multiple Sclerosis	Aug 15, 2017	EXHIBIT	PETITIONER
Adachi, et al., Design, Synthesis, and Structure-Activity Relationships of 2-Substituted-2-amino-1,3-propanediols: Discovery of a Novel Immunosuppressant	Aug 15, 2017	EXHIBIT	PETITIONER
Dumont, Fingolimod Mitsubishi Pharma/Novartis	Aug 15, 2017	EXHIBIT	PETITIONER
Park, et al., Pharmacokinetic/Pharmacodynamic Relationships of FTY720 in Kidney Transplant Patients	Aug 15, 2017	EXHIBIT	PETITIONER
Yanagawa, et al., FTY720	Aug 15, 2017	EXHIBIT	PETITIONER
Clinical Pharmacology in the Critically Ill Child	Aug 15, 2017	EXHIBIT	PETITIONER
Chiba, FTY720	Aug 15, 2017	EXHIBIT	PETITIONER
MCALPINE'S MULTIPLE SCLEROSIS	Aug 15, 2017	EXHIBIT	PETITIONER
Frohman, et al., Multiple Sclerosis, The Plaque and its Pathogenesis	Aug 15, 2017	EXHIBIT	PETITIONER
Inglese, Multiple Sclerosis	Aug 15, 2017	EXHIBIT	PETITIONER
Dragun, D., et al., FTY720: Early Clinical Experience	Aug 15, 2017	EXHIBIT	PETITIONER
Kahan, B.D., FTY720: A New Dimension in Transplantation	Aug 15, 2017	EXHIBIT	PETITIONER
Fujino, et al., Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment	Aug 15, 2017	EXHIBIT	PETITIONER
Kataoka, et al., FTY720	Aug 15, 2017	EXHIBIT	PETITIONER
Kahan, B.D., Sirolimus and FTY720: New Approaches to Transplant Immunosuppression	Aug 15, 2017	EXHIBIT	PETITIONER
Kahan, et al., Pharmacodynamics, Pharmacokinetics, and Safety of Multiple Doses of FTY720 in Stable Renal Transplant Patients	Aug 15, 2017	EXHIBIT	PETITIONER
Final Written Decision, IPR2014-00784	Aug 15, 2017	EXHIBIT	PETITIONER
PHYSICIAN'S DESK REFERENCE	Aug 15, 2017	EXHIBIT	PETITIONER
Introduction to Pharmacokinetics in BIOPHARMACEUTICS AND CLINICAL PHARMACOKINETICS	Aug 15, 2017	EXHIBIT	PETITIONER
Orange Book entry for Fingolimod	Aug 15, 2017	EXHIBIT	PETITIONER
FDA approval letter for Tysabri	Aug 15, 2017	EXHIBIT	PETITIONER
U. S. Pat. No. 8,324,283	Aug 15, 2017	EXHIBIT	PETITIONER
Kappos, L., et al., A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis	Aug 15, 2017	EXHIBIT	PETITIONER
LaMontagne, et al., Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis	Aug 15, 2017	EXHIBIT	PETITIONER
Thomson, FTY720 in Multiple Sclerosis	Aug 15, 2017	EXHIBIT	PETITIONER
Federal Circuit decision in Novartis AG v. Torrent Pharms. Ltd., No. 2016-1352 (Apr. 12, 2017)	Aug 15, 2017	EXHIBIT	PETITIONER
Petition for Inter Partes Review of U.S. Patent No. 9,187,405	Aug 15, 2017	PAPER	PETITIONER
Motion for Joinder	Aug 15, 2017	PAPER	PETITIONER